Literature DB >> 32538066

Nanopore Sequencing in a Clinical Routine Laboratory: Challenges and Opportunities.

Jonas Schmidt, Frithjof Blessing, Lea Fimpler, Folker Wenzel.   

Abstract

BACKGROUND: About forty-five years ago the advent of Sanger sequencing (Sanger and Coulson 1975) was revolutionary as it allowed deciphering of complete genome sequences. A second revolution came when next-generation sequencing (NGS) technologies accelerated and cheapened genome sequencing. Recently, third generation/longread sequencing methods have appeared, which can directly detect epigenetic modifications on native DNA and allow whole-transcript sequencing without the need for assembly. Nanopore sequencing is one of these third-generation approaches, enabling a single molecule of DNA or RNA to be sequenced in real-time without the need for PCR amplification or chemical labelling of the sample. It works by monitoring changes to an electrical current as nucleic acids are passed through protein or synthetic nanopores.
METHODS: A literature search was performed in order to collect and summarize current information about the methodological aspects of nanopore sequencing as well as some application examples.
RESULTS: The review describes concisely and comprehensibly the technical aspects of nanopore sequencing and stresses the advantages and disadvantages of this technique thereby also giving examples of their potential applications in the clinical routine laboratory as are rapid identification of viral pathogens, monitoring Ebola, environmental and food safety monitoring, human and plant genome sequencing, monitoring of antibiotic resistance, and other applications.
CONCLUSIONS: It is a useful incitation for such ones being permanently in search of upgrading their laboratory.

Entities:  

Mesh:

Year:  2020        PMID: 32538066     DOI: 10.7754/Clin.Lab.2019.191114

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  6 in total

1. 

Authors:  小芳 贾; 小楠 张; 云 凌; 欣宇 张; 棣 田; 怡馨 廖; 志刚 易; 洪洲 卢
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

2.  Application of nanopore sequencing in diagnosis of secondary infections in patients with severe COVID-19.

Authors:  Xiaofang Jia; Xiaonan Zhang; Yun Ling; Xinyu Zhang; Di Tian; Yixin Liao; Zhigang Yi; Hongzhou Lu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

3.  Genotyping of familial Mediterranean fever gene (MEFV)-Single nucleotide polymorphism-Comparison of Nanopore with conventional Sanger sequencing.

Authors:  Jonas Schmidt; Sandro Berghaus; Frithjof Blessing; Holger Herbeck; Josef Blessing; Peter Schierack; Stefan Rödiger; Dirk Roggenbuck; Folker Wenzel
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

Review 4.  Application of High-Throughput Sequencing Technology in Identifying the Pathogens in Endophthalmitis.

Authors:  Peini Cheng; Kui Dong; Zhiming Kang; Jing Li; Wenjuan Wang; Xiaodan Zhang; Guohong Zhou
Journal:  J Ophthalmol       Date:  2022-08-27       Impact factor: 1.974

Review 5.  Ten Years of EWAS.

Authors:  Siyu Wei; Junxian Tao; Jing Xu; Xingyu Chen; Zhaoyang Wang; Nan Zhang; Lijiao Zuo; Zhe Jia; Haiyan Chen; Hongmei Sun; Yubo Yan; Mingming Zhang; Hongchao Lv; Fanwu Kong; Lian Duan; Ye Ma; Mingzhi Liao; Liangde Xu; Rennan Feng; Guiyou Liu; The Ewas Project; Yongshuai Jiang
Journal:  Adv Sci (Weinh)       Date:  2021-08-11       Impact factor: 16.806

Review 6.  Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations.

Authors:  Ahmad Qasem; Ameera M Shaw; Erij Elkamel; Saleh A Naser
Journal:  Curr Issues Mol Biol       Date:  2021-07-20       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.